This drug has 5 patent member of the family in five nations.
For more details on how DrugPatentWatch can assist with your pharmaceutical company intelligence requires, contact [email protected] or go to www.DrugPatentWatch.com
Drug patent lawsuits for ISTODAX.
The generic ingredient in ISTODAX is romidepsin. 2 providers are listed for this substance. Additional information are available on the romidepsin profile page.
Istodax is a drug marketed by Celgene and is included in one NDA. It is readily available from 2 providers. There are two patents securing this drug and one Paragraph IV obstacle.
Copyright ©
DrugPatentWatch. Originally published at
New patent expiration for Celgene drug ISTODAXAnnual Drug Patent Expirations for ISTODAX
Make Better Decisions with DrugPatentWatch
Get the Daily Briefing or Try a trial
Copyright ©
DrugPatentWatch. Originally published at
New patent expiration for Celgene drug ISTODAX
Share this:
The generic component in ISTODAX is romidepsin.
LinkedIn
Twitter
Facebook
Email
Istodax is a drug marketed by Celgene and is included in one NDA. It is readily available from two providers. There are two patents safeguarding this drug and one Paragraph IV difficulty.
Related
